JHVEPhoto/iStock Editorial via Getty ImagesBristol-Myers Squibb (NYSE:BMY) on Saturday announced results from a late-stage trial for its psoriasis therapy Sotyktu…
JHVEPhoto/iStock Editorial via Getty ImagesThe FDA has reportedly approved an injectable formulation of Bristol-Myers Squibb’s (NYSE:BMY) oncology drug Opdivo. Previously,…